Badenhoop K, Schwarz G, Bingley P, Lewis V, Drummond V, Gale E A, Bottazzo G F
Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, London, England.
Tissue Antigens. 1990 Jan;35(1):32-9. doi: 10.1111/j.1399-0039.1990.tb01752.x.
HLA Class II polymorphisms were analysed in 27 families with at least one Type I diabetic proband using Southern blotting technique according to 10th Histocompatibility Workshop Standards. The probes used were DRB, DQA1, DQB1 and DOB. We have studied 108 haplotypes and performed segregation analysis with HLA serology and restriction fragment length polymorphism (RFLP) data and compared "affected" with "non-affected" haplotypes (not inherited by IDDM patients). RFLPs correlated well with DR and DQ serology and detected additional polymorphisms. In particular, DQB polymorphism analysis showed segregation of the DQw3 splits with 88.5% of the DR4 affected haplotypes bearing the DQw3.2 split (now DQw8) and 11.5% the DQw3.1 split (now DQw7) while in the non-affected DR4 haplotypes 33.3% were DQw3.2 and 66.6% were DQw3.1. Haplotype analysis showed that DR4-DQw3.2 was in strong linkage with the U fragment (2.1 kb Taq I) of DQA2 (DX alpha) and with the L fragment (5.4 kb BamH I) of DOB. This study confirms previous observations of DQB polymorphisms in heterozygous IDDM patients, supports the protective effect of DQw3.1 (DQw7) against the development of the disease and demonstrates the importance of DQw3.2 (DQw8) for susceptibility to Type I diabetes.
根据第10届组织相容性研讨会标准,采用Southern印迹技术对27个至少有一名I型糖尿病先证者的家庭进行了HLA II类多态性分析。所用探针为DRB、DQA1、DQB1和DOB。我们研究了108个单倍型,并利用HLA血清学和限制性片段长度多态性(RFLP)数据进行了分离分析,比较了“患病”和“未患病”单倍型(未被IDDM患者遗传)。RFLP与DR和DQ血清学相关性良好,并检测到额外的多态性。特别是,DQB多态性分析显示DQw3亚型的分离情况,88.5%的DR4患病单倍型携带DQw3.2亚型(现为DQw8),11.5%携带DQw3.1亚型(现为DQw7),而在未患病的DR4单倍型中,33.3%为DQw3.2,66.6%为DQw3.1。单倍型分析表明,DR4-DQw3.2与DQA2(DXα)的U片段(2.1 kb Taq I)和DOB的L片段(5.4 kb BamH I)紧密连锁。本研究证实了先前对杂合IDDM患者中DQB多态性的观察结果,支持了DQw3.1(DQw7)对疾病发展的保护作用,并证明了DQw3.2(DQw8)对I型糖尿病易感性的重要性。